Application of compound thrombosis capsule inn aspect of liver protection

A compound Xueshuantong and capsule technology is applied in the directions of capsule delivery, medical preparations containing active ingredients, and pharmaceutical formulations to achieve the effect of reducing the level of liver inflammation, congestion and bleeding.

Active Publication Date: 2014-03-26
GUANGDONG ZHONGSHENG PHARMA +1
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide the use of Compound Xueshuantong Capsules in protecting the liver, aiming to solve the problem of liver protection in the treatment of cardiovascular and cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of compound thrombosis capsule inn aspect of liver protection
  • Application of compound thrombosis capsule inn aspect of liver protection
  • Application of compound thrombosis capsule inn aspect of liver protection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.

[0012] The present invention conducts experiments by using lipopolysaccharide-induced disseminated intravascular coagulation model in rats, and finds that Fufang Xueshuantong Capsule can significantly inhibit the elevation of biochemical indicators of liver function aspartate aminotransferase and alanine aminotransferase, and reduce the The lipopolysaccharide-induced liver inflammation level reduces congestion and bleeding in the liver veins, that is, it is found that the compound Xueshuantong capsule has a protective effect on the liver.

[0013] The new application of Fufang Xueshuantong...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention is applicable to the field of Chinese patent medicines. A lipopolysaccharide-induced rat diffuse intravascular coagulation model is adopted for experimenting, and the experiment result shows that a compound thrombosis capsule can significantly inhibit the rise of liver-function biochemical indexes of aspartate aminotransferase and alanine aminotransferase, reduces the level of lipopolysaccharide-induced liver inflammation, and reduces congestion and hemorrhage phenomena in liver veins, namely finding out the new application of the compound thrombosis capsule playing a role of protecting the liver.

Description

technical field [0001] The invention belongs to the field of Chinese patent medicines, and particularly relates to the use of compound Xueshuantong capsules in protecting the liver. Background technique [0002] Cardiovascular and cerebrovascular diseases have become one of the diseases with the highest mortality in the world, and the incidence of cardiovascular and cerebrovascular diseases in my country is also rising. Since the liver is the center of the metabolism of the three major substances of sugar, fat and protein, abnormal fat metabolism can cause hyperlipidemia, increased cholesterol and triglycerides in the blood, and easily lead to atherosclerosis. Therefore, the normality of liver function is closely related to cardiovascular disease. In addition, liver cells are also the main place for the production of various coagulation factors in the human body, and the balance of coagulation and fibrinolysis in the human body also requires the normal functioning of the li...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/808A61K9/48A61P1/16A61P9/00
Inventor 苏薇薇生书晶谢称石龙超峰王锦旭刘宏李沛波王永刚彭维
Owner GUANGDONG ZHONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap